Skip to main content
Toggle navigation
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Print
Best Myeloma Abstract Presentation: Updated Progression-free Survival (PFS) and Depth of Response in IKEMA, A Randomized Phase 3 Trial of Isatuximab, Carfilzomib and Dexamethasone (Isa-Kd) vs Kd in Relapsed Multiple Myeloma (MM)
Thursday, October 20, 2022
1:30 PM – 1:40 PM